Abstract：Objective: To investigate the risk, development and metastasis of Adiponectin (ADPN), adiponectin receptor 2 (adipoR2), Leptin (LP) and leptin receptor (LEPR) in patients with colorectal cancer. Methods: 43 patients with colorectal cancer hospitalized in the proctology department of our hospital and confirmed by pathology (tumor type, cell morphology and invasion depth) were enrolled into case group, 31 healthy individuals were included into control group, the general clinical data of all the selected subjects were collected. The levels of ADPN and LP in serum were measured by ELISA, and the expression of adipoR2 and LEPR mRNA was detected by RT-PCR. Results: The BMI, FBG, TC, HDL-C, LDL-C and TG between the two groups had no significant difference (t=0.78, 0.23, 0.64, 0.93, 0.19, 0.99, P>0.05), the prevalence rate of colorectal cancer in patients with family history of colorectal cancer was higher than those patients without the family disease history, the differences were statistically significant (χ2=12.13, P<0.05); The ADPN levels and adipoR2 mRNA expression level in serum were lower than those in the control group, and the LP levels and LEPR mRNA expression level in serum were higher than those in the control group (t=2.53, 4.29, 4.75, 6.24, P<0.05); Compared with patients in stageⅠ, The ADPN levels and adipoR2 mRNA expression level in serum decreased with the increase of TNM staging in colorectal cancer, and the LP levels and LEPR mRNA expression level in serum increased with the increase of TNM staging in colorectal cancer (F=9.90, 3.52, 8.70, 9.21, P<0.05); The ADPN levels and adipoR2 mRNA expression level in serum were negatively correlated with TNM stage (r=-0.335, -0.341, -0.557, -0.492, -0.665, -0.757, -0.815, -0.753, P<0.05), while the LP levels and LEPR mRNA expression level were positively correlated with TNM stage (r=0.396, 0.516, 0.510, 0.641, 0.642, 0.628, 0.695, 0.682, P<0.05). Conclusion: ADPN levels and LP levels and their receptor expression can be used as a marker for the diagnosis of colorectal cancer. In colorectal cancer patients, the level of ADPN and its receptor expression are significantly decreased, and the level of LP and its receptor expression are increased significantly.
江勇, 谭卫林, 韩潞, 刘兵, 韩东兴. 结直肠癌患者血清脂联素瘦素及其受体表达与临床病理参数的关系[J]. 河北医学, 2018, 24(7): 1121-1124.
JIANG Yong, TAN Weilin, HAN Lu, et al. Relationship between Serum Adiponectin, Leptin and The Receptors Expression and Clinicopathological Parameters in Patients with Colorectal Cancer. HeBei Med, 2018, 24(7): 1121-1124.
[1] 郑树,张苏展,黄彦钦.结直肠癌研究30年回顾和现状[J].实用肿瘤杂志,2016,31(1):2~5. [2] Staff PO. Correction: Detection of colorectal cancer (CRC) by urinary volatile organic compound analysis[J]. Plos One, 2015, 10(3):750~758. [3] Liang J, Qiu Q, Gong Y, et al. Adiponectin Genotype, Blood Pressures, and Arterial Stiffness: The Cardiometabolic Risk in Chinese (CRC) Study[J].Clin Hypertens, 2015, 17(5):395~400. [4] 温时媛,姜苗苗.肿瘤代谢靶点用于癌症治疗的研究进展[J].中国药理学与毒理学杂志,2017,31(3):269~278. [5] Formica V, Pellicori S, Arkenau HT, et al. 1571 Ideal Body Mass Index (BMI) is significantly different between curatively resected and metastatic colorectal cancer (CRC) patients on chemotherapy[J]. European Journal of Cancer, 2015, 51(2):228. [6] 庞丽,张颐,张莹,等.脂肪细胞因子抵抗素对卵巢癌细胞增殖影响及其机制研究[J].中国实用妇科与产科杂志,2015,23(9):853~856. [7] Carroll KK, Braden LM, Bell JA, et al. Fat and cancer[J]. Cancer, 2015, 58(8):1818~1825. [8] 叶兰, 王梅,杨祖菁.脂肪细胞因子瘦素、脂联素及趋化素与胰岛素抵抗及妊娠期糖尿病的关联研究[J].现代中西医结合杂志,2015,24(2):136~139. [9] 田文艳,王颖梅,张艳芳,等.脂肪因子内脂素与恶性肿瘤关系的研究现状及展望[J].中华肿瘤杂志,2017,39(5):278~284. [10] 徐艳红,马丽娜,李耘.脂联素的心血管生物学功能研究进展[J].北京医学,2017,39(4):382~385. [11] Dodd G, Descherf S, Loh K, et al. Leptin and insulin act on POMC neurons to promote the browning of white fat[J].Cell, 2015, 160(1): 88~96. [12] 王婷, 王晋蜀,张志慧,等.乳腺癌微环境中脂肪细胞可通过瘦素促进乳腺癌MDA-MB-231细胞的增殖与迁移[J].中国细胞生物学学报,2016,27(3):249~256. [13] Gallina S, Sireci F, Lorusso F, et al. The immunohistochemical peptidergic expression of leptin is associated with recurrence of malignancy in laryngeal squamous cell carcinoma[J]. Acta Otorhinolaryngol Ital, 2015, 35(1):15~22. [14] Habib CN, Al-Abd AM, Tolba MF, et al. Leptin influences estrogen metabolism and accelerates prostate cell proliferation[J]. Life Sci, 2015, 121:10~15. [15] 杨晓宁,张辰雨,王炳蔚,等.瘦素信号与瘦素抵抗机制研究进展[J].生理科学进展,2015,26(5):327~333.
2018, Vol. 24 
冀公网安备13080202000677号